TABLE 2.

Comparison of relevant studies on distribution of resistance genes erm, msrA, and linA/linA′ among clinical isolates of CoNS

Resistance phenotypeaSpecies (nb)% of isolates with:Applied methodReference
erm genesmsrAlinA
Mets Metr Eryr S. epidermidis (142)946NDPCR 16 c
Eryr S. epidermidis (92), S. haemolyticus (22), S. hominis (22), other CoNS (36)6341NDDot blot hybridization 4 c
Mets, resistant to at least one of the following: ERY, LIN, PRI, Q/D, Q and DCoNS (41)73202PCR 14 c
Metr, resistant to at least one of the: ERY, LIN, PRI, Q/D, Q and DCoNS (109)82155PCR 14 c
Metr, resistant to at least one of the following: ERY, LIN, CLI S. epidermidis (27), S. haemolyticus (62), S. hominis (5), other CoNS (4)435324Southern blot hybridizationThis paper
  • a MET, methicillin; ERY, erythromycin; LIN, lincomycin; CLI, clindamycin; PRI, pristinamycin; Q/D, quinupristin/dalfopristin; Q, quinupristin; D, dalfopristin.

  • b n, no. of isolates.

  • c From the published data, only isolates with comparable characteristics are presented.